业绩预告
Search documents
三钢闽光:2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-28 13:19
证券日报网讯 1月28日,三钢闽光发布公告称,公司预计2025年归属于上市公司股东的净利润为2,500 万元。 (文章来源:证券日报) ...
海峡创新预计2025年度净利润1亿元至1.5亿元
Zhi Tong Cai Jing· 2026-01-28 12:22
海峡创新(300300)(300300.SZ)披露2025年度业绩预告,公司预计归属于上市公司股东的净利润1亿元 至1.5亿元,同比增长1660.56%~2540.85%;扣除非经常性损益后的净亏损9800万元至1.45亿元。 ...
*ST新潮:预计2025年全年扣非后净利润盈利约11.1亿元
Sou Hu Cai Jing· 2026-01-28 12:13
Core Viewpoint - *ST Xinchao expects a net profit of approximately 1.11 billion yuan for the year 2025 after deducting non-recurring items [1] Group 1: Performance Forecast - The company anticipates a decrease in performance primarily due to its main business operations, with a projected 13% decline in revenue compared to the previous year, influenced by falling international oil prices in 2025 [2] - The average monthly price of WTI crude oil for 2025 is forecasted to be $65.46 per barrel, a 14% decrease from $76.55 per barrel in 2024 [2] Group 2: Financial Results - For the first three quarters of 2025, the company's main revenue was 5.659 billion yuan, representing a year-on-year decline of 11.99% [2] - The net profit attributable to shareholders for the same period was 1.331 billion yuan, down 19.44% year-on-year, while the net profit after deducting non-recurring items was also 1.331 billion yuan, reflecting a 27.07% decrease [2] - In the third quarter of 2025, the company's single-quarter main revenue was 1.686 billion yuan, a decline of 18.6% year-on-year, with a net profit of 373 million yuan, down 22.42% year-on-year, and a net profit after deducting non-recurring items also at 373 million yuan, down 30.79% [2] - The company's debt ratio stands at 34.61%, with financial expenses amounting to 88.83 million yuan and a gross profit margin of 43.04% [2]
新天药业:预计2025年度净利润为750万元~1100万元,同比下降78.98%~85.67%
Mei Ri Jing Ji Xin Wen· 2026-01-28 11:44
Core Viewpoint - The company expects a significant decline in net profit for 2025, projecting a range of 7.5 million to 11 million yuan, which represents a year-on-year decrease of 78.98% to 85.67% [1] Financial Performance - The projected basic earnings per share for 2025 are between 0.0307 yuan and 0.0451 yuan [1] - The decline in performance is attributed to a decrease in operating revenue compared to the previous year, influenced by market conditions and rising production costs due to increased raw material prices [1] Non-Recurring Gains - The impact of non-recurring gains on net profit is expected to decrease compared to the previous year, primarily due to the 2024 disposal of the "Salbutamol Granules" drug license and related production technology, which added approximately 16 million yuan to net profit [1] Strategic Response - The company plans to optimize its operational management and marketing strategies to enhance market development effectiveness [1] - It will utilize a strategy combining raw material price analysis and inventory adjustments to mitigate cost pressures from rising raw material prices [1] - The company aims to improve internal management efficiency to enhance operational management and profitability [1]
北化股份:预计2025年度净利润为2.2亿元~2.9亿元
Mei Ri Jing Ji Xin Wen· 2026-01-28 11:30
每经AI快讯,北化股份1月28日晚间发布业绩预告,预计2025年归属于上市公司股东的净利润2.2亿元 ~2.9亿元,同比扭亏为盈。报告期内,公司业绩较上年同期增长的主要原因是纤维素及其衍生物产业、 防化及环保产业两大板块收入同比增长、产品毛利率水平提高。预计归属于上市公司股东的净利润比上 年同期增长877.22%~1124.52%。 (记者 王瀚黎) 每经头条(nbdtoutiao)——从极寒测试到万套装车!半固态电池今年有望搭载多款新车:各大厂商摩 拳擦掌,动力电池技术迎来迭代年 ...
瀛通通讯:预计2025年归属于上市公司股东的净利润为-6500万元至-7500万元
Mei Ri Jing Ji Xin Wen· 2026-01-28 11:13
每经头条(nbdtoutiao)——从极寒测试到万套装车!半固态电池今年有望搭载多款新车:各大厂商摩 拳擦掌,动力电池技术迎来迭代年 (记者 王晓波) 每经AI快讯,瀛通通讯1月28日晚间发布业绩预告,预计2025年归属于上市公司股东的净利润为-6500万 元至-7500万元,同比由盈转亏。基本每股收益0.35元至-0.4元。上年同期基本每股收益0.08元。业绩变 动主要原因是,报告期内,公司收入规模有所增长,但整体体量仍然偏小,规模效应尚未充分显现,单 位收入分摊的固定成本较高。报告期内,为加强品牌建设、提升品牌知名度、拓展新产品销售渠道,公 司加大了市场投入及团队组建,销售费用相应增长。报告期内,随着部分在建工程转为固定资产,折旧 费用相应增加,导致管理费用较上年度有所增长。后续,公司将充分发挥国内、国外不同生产基地的区 位优势,优化资源配置,提升对全球客户需求的响应速度与服务灵活性。公司将持续拓展新产品、新业 务及新客户,重点聚焦深化大客户服务,培育新的增长引擎,强化研发创新能力,以及精细化成本管 控,致力实现可持续、高质量的发展。 ...
泰恩康:2025年全年净利润同比预减67.66%—76.90%
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-28 11:10
南财智讯1月28日电,泰恩康发布年度业绩预告,预计2025年全年归属于上市公司股东的净利润为2500 万元—3500万元,同比预减67.66%—76.90%;预计2025年全年归属于上市公司股东的扣除非经常性损 益的净利润为2700万元—3700万元,同比预减65.11%—74.54%。业绩变动原因说明:(1)报告期内, 公司核心板块两性健康业务受竞品数量持续增加,市场竞争激烈等因素导致销售收入有所下滑,但已看 到市场需求逐步回暖的趋势。公司的"爱廷玖"盐酸达泊西汀片具有较高的品牌护城河,公司将持续加强 品牌推广力度,促进"爱廷玖"的销售回升。同时,随着新品"爱廷列"非那雄胺他达拉非胶囊的上市,预 计两性健康板块后续将保持增长。(2)报告期内,公司核心产品"和胃整肠丸"受制于泰国厂家产能不 足以及进口到货不及预期等因素,导致其销售收入有所下滑。公司正积极推进"和胃整肠丸"在国内的注 册审批进程,力争尽快实现"和胃整肠丸"在国内的生产落地,解决产能瓶颈。(3)2025年公司在坚持 加大研发投入的同时,持续增加品牌推广的投入力度和深度,导致销售费用增加,压缩了利润空间。 ...
冠农股份:预计2025年年度净利润为3.3亿元至3.4亿元,同比增加61.29%~66.18%
Mei Ri Jing Ji Xin Wen· 2026-01-28 10:57
(记者 王瀚黎) 每经头条(nbdtoutiao)——从极寒测试到万套装车!半固态电池今年有望搭载多款新车:各大厂商摩 拳擦掌,动力电池技术迎来迭代年 每经AI快讯,冠农股份1月28日晚间发布业绩预告,预计2025年度实现归属于母公司所有者的净利润3.3 亿元至3.4亿元,与上年同期相比,将增加约1.25亿元至约1.35亿元,同比增加61.29%~66.18%。业绩变 动主要原因是,本期库存商品端,棉花及棉籽深加工产品价格回暖,大包装番茄制品产量及单位成本较 上年同期均有所下降,致本期存货跌价准备计提金额较上年同期大幅减少。本期棉花及棉籽深加工业务 受益于市场行情回暖,经营业绩实现扭亏为盈,相关业务利润较上年同期明显增长。 ...
西测测试:预计2025年全年净亏损1.16亿元—1.65亿元
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-28 10:55
南财智讯1月28日电,西测测试发布年度业绩预告,预计2025年全年归属于上市公司股东的净利润为亏 损1.16亿元—1.65亿元;预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润为亏损1.17 亿元—1.66亿元。业绩变动原因说明:1、报告期内,公司持续战略性投入,短期内对净利润有所影 响:(1)产能与能力建设方面,扩建能力在报告期内陆续投入运营,相关折旧摊销、人员成本及运营 费用显著增加;(2)市场拓展方面,成立北京营销中心,积极布局新兴市场,市场开拓费用增加。上 述战略性投入是公司构筑长期竞争壁垒的必要举措,但短期内对当期利润构成了压力。2、报告期内, 电子装联业务着力优化客户结构,民品收入下降幅度较大。子公司吉通力报告期内取得NADCAP认 证、ASP证书及SPCAP证书,为后续拓展高可靠性业务奠定基础。报告期内该业务虽仍亏损,但亏损额 同比已大幅收窄。3、报告期内,检验检测市场部分领域竞争加剧,对公司部分业务的定价和毛利率水 平带来一定挑战,公司通过提升服务质量和技术附加值,并加强内部管理应对竞争,使得整体亏损程度 得到控制。4、报告期内,公司持续加强应收账款管理,主要客户均为信用良好的军 ...
远方信息:2025年全年净利润同比预减11.22%—28.54%
2 1 Shi Ji Jing Ji Bao Dao· 2026-01-28 10:37
Core Viewpoint - The company, Yuanfang Information, has released its annual performance forecast, indicating a significant decline in net profit for 2025 compared to the previous year, attributed to market changes and increased costs [1] Financial Performance - The expected net profit attributable to shareholders for 2025 is projected to be between 66 million and 82 million yuan, representing a year-on-year decrease of 11.22% to 28.54% [1] - The expected net profit after deducting non-recurring gains and losses is forecasted to be between 49 million and 63 million yuan, reflecting a year-on-year decline of 8.30% to 28.68% [1] Reasons for Performance Change - The decline in performance is attributed to a slowdown in demand for older products, underwhelming market performance of new products, and increased human resource costs [1] - Despite the decrease in revenue and net profit, the company's gross profit margin remains stable, indicating overall healthy operations [1] Non-recurring Gains - Non-recurring gains are expected to contribute approximately 19 million yuan to the net profit, primarily from investment income and government subsidies [1]